PT  - JOURNAL ARTICLE
AU  - Fujita, Kohei
AU  - Kada, Shinpei
AU  - Kanai, Osamu
AU  - Hata, Hiroaki
AU  - Odagaki, Takao
AU  - Satoh-Asahara, Noriko
AU  - Tagami, Tetsuya
AU  - Yasoda, Akihiro
TI  - Experience of quantitative SARS-CoV-2 antibody screening of health-care workers in the southern part of Kyoto city during COVID-19 peri-pandemic period
AID  - 10.1101/2020.05.12.20098962
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.12.20098962
4099  - http://medrxiv.org/content/early/2020/05/19/2020.05.12.20098962.short
4100  - http://medrxiv.org/content/early/2020/05/19/2020.05.12.20098962.full
AB  - Background Pandemic of coronavirus disease-2019 (COVID-19) puts a heavy burden not only on patients’ physical and mental health but also on regional health care resource and economic activity across the world. Although we accumulate incidence rate and case fatality rate by the multidisciplinary approach, epidemiological data of prevalence of serum severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) antibody in health-care workers during COVID-19 peri-pandemic period is insufficient.Methods We prospectively recruited health-care workers from our hospital between April 10 and April 20, 2020. We collected serum samples from these participants and evaluated quantitative SARS-CoV-2 IgG antibody by enzyme-linked immunosorbent assay.Results Five (5.4%), 15 (16.3%) and 72 (78.3%) participants showed positive, borderline and negative results of the serum SARS-CoV-2 IgG antibody, respectively. We found mean titer of the antibody levels of all, positive group, borderline group and negative group were clearly distinguished. Participants belonging to otolaryngology ward and/or having a history of seasonal common cold symptoms had significantly higher titer of SARS-CoV-2 IgG antibody (p=0.046, p=0.046, respectively).Conclusions Five (5.4%) and 15 (16.3%) participants showed positive and borderline SARS-CoV-2 IgG antibody during COVID-19 peri-pandemic period. These rates were much higher than the rates expected from situation reports of the government. Higher rates of positive and borderline antibody suggested that COVID-19 had already spread at early stage of pandemic in the southern part of Kyoto city.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study is funded by National Hospital Organization annual fiduciary funds.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data of this study is available for anyone if our institute IRB allows.